Article
Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.
Neurobiology of disease - 1 Sept 2008
Desplats Paula A, Lambert James R, Thomas Elizabeth A
Abstract excerpt
Transcriptional dysregulation has emerged as a central pathogenic mechanism in Huntington's disease (HD), which is associated with neuropathological changes predominantly in the striatum. Here we demonstrate that expression of Bcl11b (a.k.a. CTIP2), a transcription factor exhibiting highly-enriched localization in adult striatum, is significantly decreased in HD cells, mouse models and human subjects and that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
